ACT Genomics is an innovation –driven cancer solution provider in Asia with offices in Taipei, Singapore, Hong Kong & Tokyo. With our Next-Generation Sequencing (NGS) technology and experienced bioinformatics team, we provide optimal cancer treatment planning, cancer relapse and drug resistance monitoring, cancer risk assessment and immunotherapy evaluation to medical professionals.
Our team is specialized in biomarker identification, underlying disease mechanism discovery and genetic alteration exploration for academia around the world. Pharmaceutical communities also benefit from our expertise in identifying targets for drug development, stratifying patients for clinical studies and delineating drug responses with efficiency and efficacy. We ‘turn genomics into action’.
Company Details
- Employees
- 4
- Founded
- 2014
- Address
- Units 803-807, 8/f, Building 15w,, No. 15 Science Park West Avenue,hong Kong
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.actgenomics.com
- Keywords
- Lucence.
- HQ
- Hong Kong, NT
Act Genomics (Hk) Ltd Questions
Act Genomics (Hk) Ltd's website is http://www.actgenomics.com
Act Genomics (Hk) Ltd's LinkedIn profile is https://hk.linkedin.com/company/act-genomics-hk-ltd
Act Genomics (Hk) Ltd has
4 employees.
View email and phone details for 4
employees at Act Genomics (Hk) Ltd.
Act Genomics (Hk) Ltd's industry is
Biotechnology Research
Act Genomics (Hk) Ltd's top competitors are
Lucence,
Zuellig Pharma,
Phase Scientific International Limited,
Circledna,
Hong Kong Regen Medtech Limited,
Act Genomics,
Hutchmed,
Prenetics,
Advanced Batteritech Company Limited,
Im8 Health.
Act Genomics (Hk) Ltd's categories are Biotechnology Research
Act Genomics (Hk) Ltd's founding year is 2014
